Embargoes also play a big role in health and science journalism, where much of the coverage is based on research studies in peer-reviewed journals. Reporters typically get this news under embargo, either from the journals themselves or news services such as EurekAlert or Newswise. This gives them a chance to read the study, interview experts and then write the story in time for the study’s public release. There’s even a blog—Embargo Watch—devoted to the topic. The blogger, Ivan Oransky of MedPage Today, reports on cases in which outlets break embargoes and how the journals respond. He also writes about larger issues and trends involving the practice. You can learn more about the rationale behind the blog in this inaugural post.
https://www.bulldogreporter.com/not-for-immed...embargoes/

Go CTIX!!!